104 related articles for article (PubMed ID: 3641037)
1. [Effect of an acid protected, micro-encapsulated pancreatin preparation on pancreatogenic steatorrhea].
Kölbel C; Layer P; Hotz J; Goebell H
Med Klin (Munich); 1986 Feb; 81(3):85-6. PubMed ID: 3641037
[No Abstract] [Full Text] [Related]
2. [Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations].
Lankisch PG; Lembcke B; Kirchhoff S; Hilgers R; Creutzfeldt W
Dtsch Med Wochenschr; 1988 Jan; 113(1):15-7. PubMed ID: 3335192
[TBL] [Abstract][Full Text] [Related]
3. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage?
Lankisch PG; Lembcke B; Göke B; Creutzfeldt W
Z Gastroenterol; 1986 Dec; 24(12):753-7. PubMed ID: 3548109
[TBL] [Abstract][Full Text] [Related]
4. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin.
Neoptolemos JP; Ghaneh P; Andrén-Sandberg A; Bramhall S; Patankar R; Kleibeuker JH; Johnson CD
Int J Pancreatol; 1999 Jun; 25(3):171-80. PubMed ID: 10453419
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of a new microencapsulated pancreatin versus a conventional preparation, in the treatment of steatorrhea of pancreatic origin].
Aparisi L; Rodrigo JM; Serra MA; Del Olmo J; Bisquert M; Raga F
Rev Esp Enferm Apar Dig; 1989 Jul; 76(1):25-30. PubMed ID: 2799034
[TBL] [Abstract][Full Text] [Related]
6. Replacement therapy in pancreatic insufficiency with a new pancreatin preparation respecting the physiological ratio of lipase/trypsin activity.
Pap A; Varró V
Hepatogastroenterology; 1988 Apr; 35(2):83-6. PubMed ID: 3371850
[TBL] [Abstract][Full Text] [Related]
7. Raised fecal fat concentration is not a valid indicator of pancreatic steatorrhea.
Lembcke B; Grimm K; Lankisch PG
Am J Gastroenterol; 1987 Jun; 82(6):526-31. PubMed ID: 3646827
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis.
Schneider MU; Knoll-Ruzicka ML; Domschke S; Heptner G; Domschke W
Hepatogastroenterology; 1985 Apr; 32(2):97-102. PubMed ID: 2408983
[TBL] [Abstract][Full Text] [Related]
9. Enzyme treatment of exocrine pancreatic insufficiency in chronic pancreatitis.
Lankisch PG
Digestion; 1993; 54 Suppl 2():21-9. PubMed ID: 8224569
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of pancreatogenic digestive disorders. Tolerance and effectiveness of a modern pancreatic enzyme substitute].
Hedding-Eckerich M; Eckert MW
Fortschr Med; 1998 Oct; 116(29):48-9. PubMed ID: 9846474
[No Abstract] [Full Text] [Related]
11. [Steatorrhea and its treatment with pancreatic enzymes in endocrine tumors of the pancreas (pancreatic adenomas)].
Varas MJ; López A
Rev Esp Enferm Dig; 1990 Jul; 78(1):27-30. PubMed ID: 1701657
[TBL] [Abstract][Full Text] [Related]
12. Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency.
Zerega J; Lerner S; Meyer JH
Dig Dis Sci; 1988 Oct; 33(10):1245-9. PubMed ID: 3168697
[TBL] [Abstract][Full Text] [Related]
13. [Digestive action of acid-protected lipase in pancreatogenic steatorrhea].
Brackmann P; Rüther HG
Fortschr Med; 1984 Nov; 102(44):1143-5. PubMed ID: 6396183
[No Abstract] [Full Text] [Related]
14. [PANCREATIC EXOCRINE INSUFFICIENCY AND ITS CORRECTION IN CHILDREN WITH TYPE I DIABETES IN COMBINATION WITH CELIAC DISEASE].
Bolshova EV; Lukashuk IV; Lukashuk VD
Lik Sprava; 2015; (1-2):167-9. PubMed ID: 26118067
[TBL] [Abstract][Full Text] [Related]
15. [Multicenter comparative study of a new formulation of pancreatin in gastro-resistant microgranules for the treatment of exocrine pancreatic insufficiency in children with mucoviscidosis].
Duhamel JF; Vidailhet M; Le Luyer B; Douchain F; Jehanne M; Clavel R; Guillot M
Ann Pediatr (Paris); 1988 Jan; 35(1):69-74. PubMed ID: 3284429
[No Abstract] [Full Text] [Related]
16. [Therapy of exocrine pancreatic insufficiency].
Lankisch PG; Lembcke B
Dtsch Med Wochenschr; 1984 May; 109(18):720-2. PubMed ID: 6562014
[No Abstract] [Full Text] [Related]
17. Lack of dose-response with Pancrease MT for the treatment of exocrine pancreatic insufficiency in adults.
Opekun AR; Sutton FM; Graham DY
Aliment Pharmacol Ther; 1997 Oct; 11(5):981-6. PubMed ID: 9354210
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic inactivation of lipase as a possible cause of the uneven results obtained with enzyme substitution in pancreatic insufficiency.
Pap A; Varró V
Hepatogastroenterology; 1984 Feb; 31(1):47-50. PubMed ID: 6199274
[TBL] [Abstract][Full Text] [Related]
19. Fate of oral enzymes in pancreatic insufficiency.
Guarner L; Rodríguez R; Guarner F; Malagelada JR
Gut; 1993 May; 34(5):708-12. PubMed ID: 8504976
[TBL] [Abstract][Full Text] [Related]
20. [Long-term treatment of mucoviscidosis. Results with a microencapsulated pancreatic enzyme preparation].
Henker J; Hoffmann D; Paul D; Hein J; Paditz E
Fortschr Med; 1993 Feb; 111(4):53-6. PubMed ID: 8449468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
